• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

dane.vassiliadis@unimelb.edu.au

Credentials


Position
Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-7814-4851

Dr Dane Vassiliadis

Honorary Conjoint Fellow
The Sir Peter MacCallum Department of Oncology

36 Scholarly works
4 Projects

HIGHLIGHTS

  • 2025

    Other

    Figure S5 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869618
  • 2025

    Other

    Figure S7 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869612
  • 2025

    Other

    Table S2 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869606
  • 2023

    Research grants (international)

    Tracing Non-Genetic Determinants of Therapeutic Response and Relapse in Acute Myeloid Leukemia
  • 2022

    Journal article

    Non-genetic determinants of malignant clonal fitness at single-cell resolution
    DOI: 10.1038/s41586-021-04206-7
  • 2021

    Research grants (international)

    Targeting Non-Genetic Mechanisms of Therapeutic Resistance in Acute Myeloid Leukemia
  • 2019

    Journal article

    Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
    DOI: 10.1038/s41591-018-0243-z
Dane Vassiliadis

RECENT SCHOLARLY WORKS

  • 2025

    Other

    Figure S3 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869624
  • 2025

    Other

    Table S1 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869609
  • 2025

    Other

    Figure S6 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869615
  • 2025

    Other

    Figure S2 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869627
  • 2025

    Other

    Table S6 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869600
  • 2025

    Other

    Tables S4-S5 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869597
  • 2025

    Other

    Figure S1 from Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
    DOI: 10.1158/2159-8290.30869630

RECENT PROJECTS

  • 2023

    Research grants (international)

    Tracing Non-Genetic Determinants of Therapeutic Response and Relapse in Acute Myeloid Leukemia

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224